RhumbLine Advisers
NAUT icon

RhumbLine Advisers’s Nautilus Biotechnolgy NAUT Stock Holding History

RhumbLine Advisers’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69,755
Closed -$60K – 4217
2025
Q1 		$60K Sell
69,755
-3,628
-5% -$5.39K ﹤0.01% 3533
2024
Q4 		$123K Buy
73,383
+2,497
+4% +$5.97K ﹤0.01% 3411
2024
Q3 		$202K Sell
70,886
-3,729
-5% -$9.65K ﹤0.01% 3236
2024
Q2 		$175K Sell
74,615
-243
-0.3% -$634 ﹤0.01% 3304
2024
Q1 		$220K Buy
74,858
+1,928
+3% +$5.47K ﹤0.01% 3132
2023
Q4 		$218K Sell
72,930
-1,195
-2% -$3.42K ﹤0.01% 3141
2023
Q3 		$234K Buy
74,125
+2,677
+4% +$8.71K ﹤0.01% 3073
2023
Q2 		$277K Buy
71,448
+668
+0.9% +$1.92K ﹤0.01% 3065
2023
Q1 		$196K Buy
70,780
+1,394
+2% +$2.92K ﹤0.01% 2740
2022
Q4 		$125K Buy
69,386
+392
+0.6% +$757 ﹤0.01% 2876
2022
Q3 		$146K Buy
68,994
+3,763
+6% +$9.46K ﹤0.01% 2953
2022
Q2 		$175K Buy
+65,231
New +$243K ﹤0.01% 2965

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

RhumbLine Advisers's NAUT Position: Q2 2025 in Review

RhumbLine Advisers sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 69,755 shares — an estimated $60K sold.

RhumbLine Advisers first reported a position in NAUT in Q2 2022 and held it in 12 quarters. The position peaked at $277K in Q2 2023. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • RhumbLine Advisers reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 69,755 Nautilus Biotechnolgy shares in Q2 2025, an estimated $60K.
  • RhumbLine Advisers first reported a position in Nautilus Biotechnolgy in Q2 2022 and held it in 12 quarters.
  • RhumbLine Advisers's Nautilus Biotechnolgy position peaked at $277K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.